Cargando…
Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin- dependent diabetes
Glutamic acid decarboxylase (GAD) has been shown to be a target of autoantibodies in insulin-dependent diabetes (IDD). Two forms of GAD, with molecular weights of 67,000 and 65,000, have been cloned from separate genes. As pancreatic islet beta cell destruction DD is an autoimmune process mediated b...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190899/ https://www.ncbi.nlm.nih.gov/pubmed/8426122 |
Ejemplares similares
-
Epilepsy in patients with insulin-dependent diabetes and relation to glutamic acid decarboxylase 65
por: Mahmoud, Adel A., et al.
Publicado: (2020) -
Glutamate decarboxylase 67 contributes to compensatory insulin secretion in aged pancreatic islets
por: Cho, Jung Hoon, et al.
Publicado: (2019) -
Glutamic acid decarboxylase 67 expression by a distinct population of mouse vestibular supporting cells
por: Tavazzani, Elisa, et al.
Publicado: (2014) -
Corrigendum: Glutamic acid decarboxylase 67 expression by a distinct population of mouse vestibular supporting cells
por: Tavazzani, Elisa, et al.
Publicado: (2015) -
Global knockdown of glutamate decarboxylase 67 elicits emotional abnormality in mice
por: Miyata, Shigeo, et al.
Publicado: (2021)